The majority of individuals (about 65%) experience some form of low back pain at some point in their lives, making this condition second only to upper respiratory illness as a cause for visiting a physician.1,2 Many episodes of low back pain pass within a few weeks to a month (acute episode); however, individuals with continuous pain lasting 8 weeks or more after onset (chronic episode) will often have symptoms at 1 year.1,2 Low back pain as a chronic condition is a leading cause of disability worldwide.3
Mesenchymal stem cells (MSCs) are an especially good option for treating musculoskeletal conditions involving lost or injured tissue, such: as bone-on-bone arthritis, injury and tears to tendons, ligaments, and cartilage, degenerative disc disease. MSCs not only can differentiate into all the different cell types within a joint, they also control the local inflammatory response.
The word “arthritis” means “joint inflammation.” Inflammation is one of the body’s natural reactions to disease or injury, and includes swelling, pain, and stiffness. Osteoarthritis is the most common type of arthritis and is considered a degenerative disease.